Vivien de Gunzburg

Vivien de Gunzburg founded and is the President and Managing Partner since 2019 of Ceres Infrastructure Asset Management LLC, the manager of Ceres Infrastructure Private Debt Fund. Based in the U.S. the infrastructure private debt fund is dedicated to providing and structuring long term financings for the renovation of large core infrastructure assets in the U.S.

Prior to Ceres, Mr de Gunzburg established the Findercod group in 2003 in the UK, Belgium and France which provides advisory services in corporate finance (including financing solutions to corporates such as projects’ long term financing or refinancing), private equity and asset management.

Prior to Findercod, in 2002 Mr. de Gunzburg participated to the creation of a second investment banking start-up: Stephens Financial Group (“SFG”). SFG was set up to be the large capitalizations mergers and acquisitions arm of the Stephens Group in New York. The Stephens family from Little Rock (AK, US), is one of America’s most successful investing, operating, banking and political families (seeded and did the IPO of Wall Mart, financed President Bill Clinton, General Wesley Clark, etc.). While at SFG, Vivien de Gunzburg worked as a Vice President in the M&A advisory practice, serving clients in the industrial, aerospace, homeland security and life sciences areas. Mr. de Gunzburg was involved in the Northrop Grumman/TRW $13.4 billion merger and the simultaneous sale of TRW Automotive to The Blackstone Group for $4.7 billion. Mr. de Gunzburg was also involved in the origination and analysis of private equity investment opportunities for the Stephens Group.

From 1998 to 2002, Mr. de Gunzburg was part of the Banking Group of Lazard Frères & Co. LLC in New York. In 2001, while at Lazard, Mr. de Gunzburg was a Senior Associate dedicated exclusively to and working in duo for Ambassador Felix Rohatyn. While participating to the creation of Rohatyn Associates, Mr. de Gunzburg originated deals for clients such as Comcast (which led to the merger of Comcast with AT&T) for $72bn, HSBC’s acquisition of Household International for $16bn, Suez, Sodexho, LVMH, Publicis, Fiat, Fimalac, United Technologies and Pfizer. Prior to working with Ambassador Rohatyn within Rohatyn Associates, in 2000 Mr. de Gunzburg was an Associate in the Industrial and Retail Group at Lazard. From 1998 to 2000, Mr. de Gunzburg was an Analyst in the Lazard Life Sciences Group, working for Kenneth Jacobs, currently worldwide chairman of Lazard. Transactions executed included Pfizer’s hostile acquisition of pharmaceutical Warner-Lambert for $116 billion and simultaneous divestiture of lice treatment Rid to Bayer for $85 million (2001), the sale of engineered nutrition food MET-Rx to Rexall Sundown for $106 million (2000), Hoechst and Rhône-Poulenc merger-of-equals into Aventis for $45 billion (1999) which later were merged with Sanofi, and the sale of the remaining 80% of Pioneer Hi-Bred to DuPont for $7.7 billion (1999).

Prior to joining Lazard, Mr. de Gunzburg worked at Rothschild & Cie. in Paris in 1997 as an Analyst in the Mergers and Acquisitions department advising clients in the industrial, financial, real-estate and technology sectors. In 1995 and 1996, he worked at Société Générale as an analyst in the Credit department both in Madrid and in Hong Kong. In 1994 Mr. de Gunzburg worked at Sanofi Beauté in Barcelona.Prior to that, in 1993, he worked at Republic New York Corporation (Republic National Bank and Safra Bank) in the Mergers and Acquisitions department in New York.

A French and Belgian national, Mr. de Gunzburg received a MSc. in financial engineering from E.S.L.S.C.A. and a BA with honors from the Institut Supérieur de Gestion in Paris. Mr. de Gunzburg is fluent in French, English and Spanish and has notions of Japanese, Russian and German. Vivien is a Young Leader (promotion President Macron) and member of the Board of Directors of the French-American Foundation in France, the founder and President of the de Gunzburg Myeloma Research Foundation in the U.S., a Member of the Executive Committee and Treasurer of French Foundation for the Research on Myeloma and Gammopathy (FFRMG) in France, World ORT Board of Trustees member, Chairman of ORT International Cooperation, President of Union ORT in France, Vice-President of ORT Belgium, and a member of the Board of Directors of ORT America and ORT France, Vice President and member of the General Committee of The Travellers club in France.